Physician

Praveen Kumar Tumula, M.D

According to 2025 Medicare claims, Praveen Tumula, M.D (NPI: 1447402896) practices hematology/oncology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 79124-2167. Tumula is affiliated with the Texoma Clinical Partners ACO, LLC (ACO ID: A4585), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Tumula's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,432 traditional Medicare patients, billed 261,496 HCPCS/CPT codes, and received $3,306,074 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,935 prescription claims across 412 beneficiaries totaling $12,651,431 in drug costs, led by Revlimid (Lenalidomide). DME data shows 46 claims. Open Payments data shows 167 records totaling $1,088,124. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $198,841 to $3,306,074. Similarly, Part D prescription costs have moved sharply higher in recent years, from $152,403 to $12,651,431. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,908 and ending at $3,817.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	235	19,690	$198,841
2016	624	119,054	$1,480,540
2017	1,069	221,943	$2,521,458
2018	1,053	195,748	$2,291,625
2019	1,362	314,155	$3,750,551
2020	1,385	312,910	$4,088,665
2021	1,592	387,660	$4,531,876
2022	1,533	341,065	$4,569,008
2023	1,454	323,384	$3,443,909
2024	1,432	261,496	$3,306,074

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	44	189	$152,403
2016	106	807	$951,170
2017	177	1,637	$2,820,181
2018	231	2,159	$3,915,598
2019	335	3,102	$5,829,271
2020	355	3,460	$7,998,953
2021	392	3,791	$10,755,351
2022	402	4,000	$12,071,027
2023	377	3,553	$10,295,353
2024	412	3,935	$12,651,431

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$1,015
2016	N/R	46	$3,454
2017	N/R	57	$1,704
2018	N/R	32	$4,281
2019	N/R	12	$559
2020	N/R	59	$3,837
2021	N/R	85	$2,618
2022	N/R	N/R	N/R
2023	N/R	12	$572
2024	N/R	46	$3,267

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	404	908	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	928	2,183	$61
80053	Blood test, comprehensive group of blood chemicals	846	2,656	$10
36415	Insertion of needle into vein for collection of blood sample	822	2,366	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	814	2,522	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	201	5,614	$2,964,734
Brukinsa	Zanubrutinib	128	3,990	$1,664,718
Jakafi	Ruxolitinib Phosphate	100	2,990	$1,591,254
Pomalyst	Pomalidomide	75	2,079	$1,420,957
Imbruvica	Ibrutinib	73	2,108	$1,023,167

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	27	$2,907
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	19	$360

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$2,680	Janssen Scientific Affairs, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	161	$1,085,444	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Praveen Kumar Tumula, M.D?

Tedicare shows public-source Medicare data for Praveen Kumar Tumula, M.D (NPI 1447402896), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Praveen Kumar Tumula, M.D have ACO affiliation data?

Praveen Kumar Tumula, M.D is shown with ACO affiliation data for Texoma Clinical Partners ACO, LLC (MSSP, ACO ID A4585), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Praveen Kumar Tumula, M.D?

Praveen Kumar Tumula, M.D is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Praveen Kumar Tumula, M.D have Open Payments data?

Praveen Kumar Tumula, M.D has 167 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.